Life Technologies Corp.

Company Website

5791 Van Allen Way
Carlsbad, CA 92008

Company Est.:

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Life Technologies Corp.

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$12,744,035,156

Market Cap as of 06/26/2012

$7,812,732,422

Market Cap as of 01/04/2012

$7,142,454,000

Market Cap as of 06/20/2011

$9,294,035,000

Market Cap as of 01/06/2011

$10,531,440,000

Exchange and Ticker Symbol

Nasdaq: LIFE

Fields of Research

Molecular biology-based technologies;
cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function;
capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents, as well as reagent kits

Major Products

Geneart Next Generation Cloning and Assembly Tools, Ion Total RNA-Seq Kit, Floid Cell Imaging Station

View all the companies in San Diego Publicly Traded Companies

Life Technologies Corp.

Market Cap as of 7/03/2014

Exchange

NASDAQ GS

Ticker

LIFE

View all the companies in Manufacturers

Life Technologies Corp.

Number of local employees in 2013

1,484

Number of local full-time employees in 2013

1,476

Number of local part-time employees in 2013

8

Products manufactured

Medical and translational research, human identification, forensics, stem cell therapies, genetic analysis, genetic engineering, agriculture biotechnology, food safety, and animal health

Executives

Greg Lucier

  • Chairman
  • Chief Executive Officer

Related News

Articles

Biotech execs discuss future of health care

Information is power, and pairing data with technologies is the secret to transforming the health care system for the better.

Tech pioneers discuss innovation's future

Saturday mornings in San Diego are for surfing, farmers markets, hiking – and talking innovation policy.

NuVasive CEO Lukianov resigns after reimbursement probe

Spinal device maker NuVasive says chairman and CEO Alex Lukianov resigned after the board concluded he didn't follow expense reimbursement and personnel policies.

Similar Companies

Biological Product (except Diagnostic) Manufacturing325414
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES2836
Subscribe Today!